Previous studies have demonstrated that astragalin could increase the sensitivity of lung cancer cells to apoptosis by regulating caspase-dependent and NF-κB signaling pathways, and reducing TNF-α- or LPS-induced inflammatory NF-κB pathways activation (Chen et al., 2017). This evidence concerns the gene NFKB1 and lung carcinoma.